ISO 8537-2016 PDF

Full title and description

St ISO 8537-2016 — Sterile single-use syringes, with or without needle, for insulin. This International Standard specifies requirements and test methods for empty, sterile, single-use plastic syringes intended to be filled by the end user with insulin and used immediately for injection.

Abstract

ISO 8537:2016 defines design, material and performance requirements, inspection and test methods, and labelling/packaging considerations for single-use sterile insulin syringes (with or without needles). The standard focuses on safety and dosing accuracy for syringes that are supplied empty and filled by the end user, and it excludes glass syringes, pre-filled syringes, syringes for power-driven pumps and syringes intended for long-term storage after filling.

General information

• Status: Published (Edition 3).
• Publication date: March 2016.
• Publisher: International Organization for Standardization (ISO).
• ICS / categories: 11.040.25 (Transfusion, infusion and injection equipment).
• Edition / version: Edition 3 (2016).
• Number of pages: 27 pages (ISO edition).

Scope

Applies to empty, sterile, single-use syringes made of plastic, with or without attached needles, intended solely for the injection of insulin after filling by the end user. The standard covers functional and safety aspects required for human use including dimensional criteria, performance tests and packaging/labelling. Exclusions include glass syringes, syringes pre-filled by the manufacturer, syringes for use with powered syringe pumps and syringes intended to be stored after filling (for example in kits).

Key topics and requirements

• Design and dimensional requirements (nominal capacities, graduations and tolerances).
• Materials of construction suitable for medical use and compatibility with insulin (plastic components, elastomeric seals where applicable).
• Sterility requirements and validated terminal sterilization or aseptic processing as applicable.
• Performance tests including leakage/seal integrity, glide force (plunger friction), dose accuracy and repeatability, and dead-space measurement.
• Mechanical strength and resistance to breakage during normal use.
• Labelling and instructions for use (capacity markings, needle information, single-use statement, storage and handling instructions).
• Packaging requirements to maintain sterility and protect device integrity during transport and storage.
• Acceptance criteria, sampling and test methods for routine quality control and type testing.

Typical use and users

Primary users are manufacturers and designers of insulin syringes, medical device quality and regulatory teams, testing laboratories performing type and batch testing, procurement specialists in hospitals and clinics, and regulatory authorities assessing device conformity. The standard is used to guide product development, production quality control and conformity assessments related to single-use insulin syringes.

Related standards

Standards commonly referenced alongside ISO 8537 include standards for needles and needle tubing (for example ISO 7864 and ISO 9626), standards for sterile packaging and terminal sterilization (for example ISO 11607 and ISO 11137), connector and fitting standards referenced in test methods (for example ISO 594 series), and other medical-device quality and regulatory standards such as ISO 13485. The ISO 8536 series (infusion equipment) and national/adopted EN versions are also relevant for related fluid-delivery devices.

Keywords

insulin syringe, single-use syringe, sterile syringe, syringe performance, glide force, leakage test, dead space, dose accuracy, ISO 8537, medical device standard

FAQ

Q: What is this standard?

A: ISO 8537:2016 is an international standard that specifies requirements and test methods for empty, sterile, single-use plastic syringes (with or without needles) intended for insulin injection after filling by the end user.

Q: What does it cover?

A: It covers design and dimensional requirements, material suitability, sterility and packaging, performance tests (leakage, glide force, dose accuracy, dead space), mechanical integrity, labelling and acceptance/testing procedures. It excludes pre-filled syringes, glass syringes, syringes for powered pumps and syringes intended for storage after filling.

Q: Who typically uses it?

A: Manufacturers of insulin syringes, product designers, quality and regulatory teams, test laboratories, procurement/specification writers in healthcare, and conformity assessment bodies.

Q: Is it current or superseded?

A: ISO 8537 was published in March 2016 (Edition 3). ISO records indicate it was reviewed after publication; users should check the ISO catalog or national standards body for any amendments, confirmations or newer revisions before relying on it for regulatory submissions or product development.

Q: Is it part of a series?

A: Not in a numbered multipart series itself, but it is closely related to other medical-device standards (for needles, tubing, sterilization and packaging). It is used alongside standards such as ISO 7864 (hypodermic needles), ISO 9626 (needle tubing), ISO 11607 (packaging for terminally sterilized devices) and relevant ISO/TC 84 publications.

Q: What are the key keywords?

A: Insulin syringe, sterile, single-use, dose accuracy, glide force, leak test, dead space, syringe design, ISO 8537.